REFRACTORY CHILDHOOD RHABDOMYOSARCOMA

Clinical trials for REFRACTORY CHILDHOOD RHABDOMYOSARCOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY CHILDHOOD RHABDOMYOSARCOMA trials appear

Sign up with your email to follow new studies for REFRACTORY CHILDHOOD RHABDOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Targeted drug trial offers hope for kids with Tough-to-Treat cancers

Disease control Ongoing

This study is testing a drug called erdafitinib in children and young adults with advanced cancers that have returned or not responded to standard treatments. It is for patients whose tumors have specific genetic changes (FGFR mutations). The goal is to see if the drug, which is …

Matched conditions: REFRACTORY CHILDHOOD RHABDOMYOSARCOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 10, 2026 12:52 UTC

REFRACTORY CHILDHOOD RHABDOMYOSARCOMA

Get alerted when new REFRACTORY CHILDHOOD RHABDOMYOSARCOMA trials appear

Targeted drug trial offers hope for kids with Tough-to-Treat cancers